Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients

Hussein Chalhoub; Michael Tunney; J. Stuart Elborn; Anne Vergison; Olivier Denis; Patrick Plésiat; Barbara C. Kahl; Françoise Van Bambeke; Paul M. Tulkens

doi:10.1093/jac/dku551

Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients

Hussein Chalhoub
, Michael Tunney
, J. Stuart Elborn
, Anne Vergison
, Olivier Denis
, Patrick Plésiat
, Barbara C. Kahl
, Françoise Van Bambeke
, Paul M. Tulkens^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

30 Citations (Scopus)

Original language	English
Article number	dku551
Pages (from-to)	1596-1598
Number of pages	3
Journal	Journal of Antimicrobial Chemotherapy
Volume	70
Issue number	5
Early online date	14 Jan 2015
DOIs	https://doi.org/10.1093/jac/dku551
Publication status	Published - May 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Carbapenemases
Esbls
Extended-spectrum β-lactamases
P. aeruginosa
β-lactamase inhibition

ASJC Scopus subject areas

Pharmacology
Microbiology (medical)
Infectious Diseases
Pharmacology (medical)

Access to Document

10.1093/jac/dku551

Cite this

Chalhoub, H., Tunney, M., Stuart Elborn, J., Vergison, A., Denis, O., Plésiat, P., Kahl, B. C., Van Bambeke, F., & Tulkens, P. M. (2015). Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients. Journal of Antimicrobial Chemotherapy, 70(5), 1596-1598. Article dku551. https://doi.org/10.1093/jac/dku551

@article{42576fe90a46455d9b4b84b014c80838,

title = "Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients",

keywords = "Carbapenemases, Esbls, Extended-spectrum β-lactamases, P. aeruginosa, β-lactamase inhibition",

author = "Hussein Chalhoub and Michael Tunney and \{Stuart Elborn\}, J. and Anne Vergison and Olivier Denis and Patrick Pl{\'e}siat and Kahl, \{Barbara C.\} and \{Van Bambeke\}, Fran{\c c}oise and Tulkens, \{Paul M.\}",

year = "2015",

month = may,

doi = "10.1093/jac/dku551",

language = "English",

volume = "70",

pages = "1596--1598",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "5",

}

Chalhoub, H, Tunney, M, Stuart Elborn, J, Vergison, A, Denis, O, Plésiat, P, Kahl, BC, Van Bambeke, F & Tulkens, PM 2015, 'Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients', Journal of Antimicrobial Chemotherapy, vol. 70, no. 5, dku551, pp. 1596-1598. https://doi.org/10.1093/jac/dku551

Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients. / Chalhoub, Hussein; Tunney, Michael; Stuart Elborn, J. et al.
In: Journal of Antimicrobial Chemotherapy, Vol. 70, No. 5, dku551, 05.2015, p. 1596-1598.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients

AU - Chalhoub, Hussein

AU - Tunney, Michael

AU - Stuart Elborn, J.

AU - Vergison, Anne

AU - Denis, Olivier

AU - Plésiat, Patrick

AU - Kahl, Barbara C.

AU - Van Bambeke, Françoise

AU - Tulkens, Paul M.

PY - 2015/5

Y1 - 2015/5

KW - Carbapenemases

KW - Esbls

KW - Extended-spectrum β-lactamases

KW - P. aeruginosa

KW - β-lactamase inhibition

UR - https://www.scopus.com/pages/publications/84929761996

U2 - 10.1093/jac/dku551

DO - 10.1093/jac/dku551

M3 - Letter

C2 - 25587996

AN - SCOPUS:84929761996

SN - 0305-7453

VL - 70

SP - 1596

EP - 1598

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 5

M1 - dku551

ER -

Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this